Disinfection By-products: A Question of Balance by Schoeny, Rita
A 466  v o l u m e 118 | number 11 | November 2010  •  Environmental Health Perspectives
Perspectives | Editorial
By all accounts, disinfection of drinking water is one of the major public   
health triumphs of the 20th century. No human endeavor, however, 
is without risk; more than 30 years ago it was determined that chlori­
nation of water resulted in formation of disinfection by­products 
(DBPs). Several of these, such as the trihalomethanes (THMs) and 
haloacetic acids (HAAs), were subsequently observed to produce cancer 
in animal models and to have other toxic end points, such as reproduc­
tive and developmental effects. Moreover, some of these end points 
have been associated with consumption of disinfected water in human 
populations; in particular, an elevated risk for bladder cancer has been 
observed in published epidemiology studies. Many governments have 
set limits on the amount of DBPs that may be present in drinking 
water produced by public systems. The U.S. Environmental Protection 
Agency (EPA), for exam­
ple, has regulatory limits 
of 80 μg total THMs and 
60 μg total HAA per liter 
of water (Richardson et al. 
2007). However, regula­
tions must also ensure that 
efforts to reduce DBPs do 
not result in water that is 
impaired due to microbial 
contamination: This is the 
microbe–DBP balanc­
ing act of minimizing risk 
while maximizing benefi­
cial effects. 
In this issue of EHP, 
a suite of four articles 
builds upon the hundreds 
of studies (see Richardson 
et al. 2007) reported since 
the first report of the 
genotoxicity of disinfected 
water (Loper et al 1978). 
These articles include a 
case–control study of gene–environment interaction in bladder can­
cer and three studies of DBP exposures in swimming pool water and 
biomarkers of their potential effects among swimmers. In the case–
control study, Cantor et al. (2010) estimated associations between 
bladder cancer and individual DBP exposure estimates based on 
THM measurements in municipal water sources that were linked to 
residential history. The authors report that participants who carried a 
glutathione S­transferase zeta­1 (GSTZ1) rs1046428 poly  morphism 
and were missing one or both copies of GSTT1 appeared to be par­
ticularly susceptible to bladder cancer when exposed to relatively high 
levels of THMs in water [odds ratio = 5.9 (95% confidence interval, 
1.8–19.0) for > 49 μg versus ≤ 8 μg THMs/L]. The two susceptibil­
ity alleles occurred together in 29% of the Spanish study population 
(Cantor et al. 2010).
Richardson et al. (2010) identified > 100 DBPs in water samples 
from two indoor pools in Barcelona, Spain (one chlorinated and 
one brominated). The samples included some nitrogen­containing 
DBPs that had not been found previously in drinking water, which 
the authors suggest may have formed due to the presence of nitrogen 
sources in pool water, such as urine or sweat. Nonetheless, they report 
that mutagenic potencies of the pool water (based on the Salmonella 
assay) were similar to that of typical drinking water.
Kogevinas et al. (2010) report that bathers in the chlorinated 
Barcelona pool had an increased frequency of micronuclei in periph­
eral blood cells (a marker of DNA damage) and evidence of increased 
systemic exposure to mutagens (based on urinary mutagenicity using 
the Salmonella assay) after a 40­min swim. Both end points were 
also associated with the concentrations of brominated THMs—but 
not chloroform—in the exhaled breath of the swimmers. In addi­
tion, Font­Ribera et al. (2010) report that Clara cell secretor protein 
(CC16), an indicator of increased lung epithelium permeability, was 
increased after swimming in the same chlorinated pool. As noted by 
the authors, alterations in Clara cell permeability are thought to play 
a role in the development of asthma, which has been linked to indoor 
swimming pool exposure. However, both exercise and DBP exposure 
could have contributed to the increase in CC16 after swimming. 
Collectively, these studies provide the clearest evidence to date that 
dis  infected water might be genotoxic and carcinogenic to humans, 
and that genotype may be a critical factor in susceptibility to bladder 
cancer in individuals exposed to DBPs. However, these research­
ers emphasize that their results need to be replicated and note that 
another case–control bladder cancer study is currently under way by 
the U.S. National Cancer Institute (National Institutes of Health). 
How can these data be used by regulators? I suggest again that 
it is a matter of balance. Swimming is generally considered to be a 
health­enhancing activity; it can be a good aerobic exercise, contribute 
to flexibility and muscle strength, and can have positive social aspects. 
However, after water leaves a public water system and enters a pool, its 
quality is not regulated at the national level in the United States as it is 
in some countries, and the Safe Drinking Water Act makes no stipula­
tion that tap water meet any additional requirements for use in pools 
or spas. Instead, pool water quality is managed at the most local level in 
the United States, usually by state or local public health departments, 
and sometimes by pool managers or lifeguards. In the pool balanc­
ing act, one must weigh immediate hazards that might result from 
exposure to microbial pathogens if adequate disinfection levels are not 
maintained against potential long­term hazards associated with expo­
sure to DBPs. In addition, regulators must also consider the cost of 
delivering high­quality water to the consumer. One option to decrease 
the responsibility and expense incurred by public drinking water sys­
tems is to improve the quality of source water through pollution pre­
vention and precursor removal. However, a source reduction approach 
is challenging for swimming pools, because the swimmers themselves 
are the largest source of nitrogenous substrates and a substantial source 
of organic matter necessary for DBP formation. 
What is next for regulatory groups? It may be time to consider the 
feasibility of a population­based risk assessment for DBPs based on the 
evolving knowledge of genetic susceptibility to DBP­associated cancer. 
Any risk management approach for DBPs must be balanced against 
risk of waterborne disease, without exquisite information on genetic 
or life­stage susceptibility for these diseases. In addition, increased 
emphasis on DBPs, or any class of contaminants, will be balanced 
against the need for research and risk assessment for chemicals not 
currently addressed by regulations. 
Tools are available to help in sorting priorities for risk assessment 
in support of risk management. Also in this issue of EHP, Claxton 
et al. (2010) review the 40­year history of the Salmonella mutagenicity 
assay and discuss that history informs the development of 21st century 
toxicology. The Salmonella mutagenicity assay was used > 30 years ago 
in the first report of the mutagenic potential of drinking water (Loper 
et al. 1978), and it continues to be used in hazard identification, as 
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evidenced by the current swimmer studies. In this century, we need 
to use all of the tools available to us—advanced analytical meth­
ods, genomic end points, and engineering approaches—to guarantee 
the delivery to all of water that is safe for drinking, bathing, and 
swimming. 
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ISEE is delighted to announce that its second annual award 
for the Best Environmental Epidemiology Paper has been granted to 
 
C. Arden Pope III, Majid Ezzati, and Douglas W. Dockery 
for their paper on 
Fine-Particulate Air Pollution and Life Expectancy in the United States 
published in New England Journal of Medicine 
January 22, 2009: 360:376-386 
 
The paper makes an outstanding contribution to the knowledge of environmental 
epidemiology and was selected because of its quality, originality, importance and 
expected impact. 
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